Original language | English |
---|---|
Article number | P045 |
Pages (from-to) | E33-E34 |
Number of pages | 2 |
Journal | Melanoma Research |
Volume | 26 |
Publication status | Published - Aug 2016 |
Event | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 2 Jun 2016 → 7 Jun 2016 |
Single-center 'real life experience' with pembrolizumab (PEMBRO) in advanced melanoma patients and analysis of baseline factors that correlate with outcome
Y. Jansen, M. Schreuer, B. Neyns
Research output: Contribution to journal › Meeting abstract (Journal)